TMC Pharma Services Ltd logo — Your strategic partner in advancing patient health

TMC Pharma Services Ltd

Your strategic partner in advancing patient health

Founded 2000 United Kingdom United Kingdom 81 employees Private Equity Total: $18.00M Biotechnology, Health Care +1

General Information

Company Name TMC Pharma Services Ltd
Founded Year 2000
Location United Kingdom United Kingdom
Employees 81
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Private Equity
Business Model B2B, B2B2B
Revenue Model Service Fee, Consulting Fee, Project Based
Social

BounceWatch is an independent company data service, not affiliated with TMC Pharma Services Ltd. To contact TMC Pharma Services Ltd, visit tmcpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TMC Pharma Services Ltd compare?

A PDF of TMC Pharma Services Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TMC Pharma Services Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TMC Pharma Services Ltd

TMC Pharma Services Ltd is a dynamic player in the pharmaceutical services sector, known for its slogan, "Your strategic partner in advancing patient health." Founded in 2000, the company is headquartered in the United Kingdom and operates primarily within the Biotechnology, Health Care, and Pharmaceutical industries.

With a focus on enhancing the speed and value of drug development, TMC partners with small to mid-sized biotech and pharma firms to shepherd projects from clinical development to market access. Their comprehensive services range from clinical execution to drug commercialization, backed by cross-functional teams proficient in regulatory affairs, clinical development, and pharmacovigilance.

Their adaptability and insight into rare diseases and new therapeutic modalities make them an attractive collaborator, especially for companies targeting EU and UK markets. TMC's growth is underscored by a recent £18.00M Private Equity Round led by investor LDC on 08 August 2022, marking a significant endorsement of their market positioning and capabilities.

Business keywords: pharma services, drug development, biotech partnerships, clinical development, regulatory affairs, pharmacovigilance, medical services, market access, drug commercialisation, oncology, orphan drugs, rare disease treatments, CRO services, quality assurance, medical writing

Services & Products

Consulting
Clinical Development
Commercialisation
Regulatory Affairs
Pharmacovigilance
Quality Management

Target Customers

Small to Mid-sized Biotech Companies Pharma Companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round £18.00M 1
LDC
08 Aug 2022

TMC Pharma Services Ltd Alternatives & Competitors

View All Alternatives
TMC Pharma Services Ltd vs
tranScrip
tranScrip United Kingdom

tranScrip is now part of TMC, a global pharma services company offering end-to-end drug development...

Growth
68 employees
Biotechnology, Health Care
TMC Pharma Services Ltd vs
Simbec-Orion
Simbec-Orion United Kingdom

Flexible, high-quality, Phase I - IV clinical trial solutions, delivered with integrity.

306 employees
Biotechnology, Pharmaceutical
TMC Pharma Services Ltd vs

Streamline & Accelerate Cross-border Clinical Trial Pathways

Series A
108 employees
Biopharma, Biotechnology

FAQ About TMC Pharma Services Ltd

Your strategic partner in advancing patient health
TMC Pharma Services Ltd was founded in 2000.
TMC Pharma Services Ltd is headquartered in United Kingdom.
TMC Pharma Services Ltd operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharma services, drug development, biotech partnerships and clinical development. Its customers include Small to Mid-sized Biotech Companies and Pharma Companies.
TMC Pharma Services Ltd has a B2B and B2B2B business model. Its revenue comes from Service Fee, Consulting Fee and Project Based.
TMC Pharma Services Ltd has approximately 81 employees.
TMC Pharma Services Ltd has completed 1 funding round, raising a total of $18.00M. The latest funding stage is Private Equity.
TMC Pharma Services Ltd offers: Consulting, Clinical Development, Commercialisation, Regulatory Affairs, Pharmacovigilance, Quality Management.
Top alternatives and competitors to TMC Pharma Services Ltd include tranScrip, Simbec-Orion, HiRO - Harvest Integrated Research Organization, Global Clinical Trials (GCT), Apollo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TMC Pharma Services Ltd and tranScrip are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TMC Pharma Services Ltd, https://bouncewatch.com/company/tmc-pharma-services-ltd, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes